New York, United States, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Perfusion can be described as the delivery of oxygenated blood to the body's tissues. Organ transplants rely heavily on perfusion systems, which help replace the organ's function by pumping blood throughout the body throughout the operation.
According to Straits Research, “The global perfusion system market size was valued at USD 1.062 billion in 2021 and is projected to reach USD 1.64 billion by 2030, registering a CAGR of 4.95% from 2022 to 2030.” Due to Increasing approvals and releases of innovative perfusion systems will drive market expansion in the near future. In 2014, the FDA authorized Xvivo Perfusion AB's XPS with STEEN solution for preserving originally rejected donor lungs while they are evaluated as transplantable organs. In February 2018, Europe approved Paragonix's SherpaPak and SherpaPerfusion cardiac transport systems. SherpaPak Cardiac Transport System is used for hypothermic static storage and transport of donor’s hearts, while SherpaPerfusion Cardiac Transport System is a single-use, disposable device. Increasing investment by industry leaders should also boost the global perfusion system market. In January 2018, Miracor Medical Systems GmbH (Miracor Austria) and Miracor Medical SA (Miracor Medical) raised $26.3 million. The funds will be used to develop and market PiCSO Impulse. Increasing organ transplants are predicted to boost the market for perfusion systems. According to the National Kidney Foundation, 100,791 Americans are waiting for kidney transplants in 2016.
Download Free Sample Report PDF @ https://straitsresearch.com/report/perfusion-system-market/request-sample
The high price of perfusion systems is anticipated to be the primary factor impeding the expansion of the global perfusion system market. According to 2016 data given by the National Institute for Health and Care Excellence, the cost of a single-use Organ Care System (OCS) Heart Perfusion Set is around US$ 36,904.8, which is prohibitively expensive for developing nations such as India, China, and Africa.
Growth Opportunities
It is anticipated that the increased demand for organ transplantation would raise the demand for dependable organ perfusion systems. In addition, the prevalence of cardiovascular and respiratory disorders is increasing globally, which increases the demand for organ transplants. In 2018, there were 3,408 heart transplants, as reported by the Division of Transplantation (DoT) of the Health Resources and Services Administration's Healthcare Systems Bureau of the Department of Health and Human Services. As a result of the increased need for organ transplantation and the incidence of cardiovascular and respiratory disorders, the market is anticipated to experience rapid expansion.
Regional analysis
The market is split by region into North America, Europe, Asia-Pacific, and LAMEA.
It is anticipated that North America will have a leading position in the global perfusion system market due to the high concentration of key companies and their expanding partnerships to expand their product's reach in the region. In 2016, for instance, the U.S.-based medical device manufacturer Medtronic plc partnered with Spectrum Medical Ltd. to distribute Spectrum Medical's innovative Quantum Perfusion Systems in Canada and other locations. In 2017, Paragonixc Technologies, Inc. signed a strategic distribution deal with MBA Medical to offer SherpaPak Cardiac and Kidney Transport Systems in the southern United States. In addition, Europe is anticipated to have considerable growth in the global perfusion system market due to the region's rising approvals of novel perfusion systems. Limflow SA acquired CE marking in 2016 for their most recent percutaneous LimFlow System intended for venous arterialization of the lower limbs in patients with end-stage danger of limb amputation due to Critical Limb Ischemia.
Key Highlights
- The cardiopulmonary perfusion system held the highest revenue share of more than 43% in 2021
- North America is expected to hold a dominant position in the global perfusion system market
Competitive players
- Bridge to Life (Europe) Ltd.
- Organ Assist B.V.
- Organ Recovery Systems, Inc,
- OrganOx Limited
- Paragonix Technologies, Inc.
- Preservation Solutions Inc.
- TransMedics, Inc.
- Waters Medical Systems LLC
- XVIVO Perfusion AB
Recent Developments by key players
In March 2018, Sartorius Stedim Biotech SA has introduced the ambr 250 high throughputs (ht) perfusion, a new parallel automated bioreactor system. The ambr 250ht perfusion system is intended for optimizing the generation of therapeutic antibodies through the rapid development of cell culture perfusion processes.
The global perfusion system market segmentation
By Product Type
- Cardiopulmonary Perfusion Systems
- Ex Vivo Organ Perfusion Systems
- Cell Perfusion Systems
By Component
- Heart-Lung Machines
- Perfusion Pumps
- Oxygenators
- Monitoring Systems
- Cannulas
- Others
By End-User
- Hospitals
- Ambulatory Surgery Centers
- Others
By Region
- North America
- Latin America
- Europe
- The Asia Pacific
- The Middle East and Africa
Get Detailed Market Segmentation @ https://straitsresearch.com/report/perfusion-system-market/segmentation
About Straits Research Pvt Ltd.
Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, specially designed and presented for decision making and ROI.
Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.
For more information on your target market, please contact us below:
Phone: +1 646 480 7505 (the U.S.)
+91 8087085354 (APAC)
+44 208 068 9665 (the U.K.)
Email: sales@straitsresearch.com
Follow Us: LinkedIn | Facebook | Instagram | Twitter
